Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Is it over?
View:
Post by CrackpotJackpot on Oct 28, 2022 9:52am

Is it over?

What happened here?
Comment by cashworx48 on Oct 28, 2022 9:57am
This post has been removed in accordance with Community Policy
Comment by MaterialWorld on Nov 03, 2022 7:21am
Here's a better question Crackpot. I can't wait to get an answer. You signed up with Stockhouse on Feb. 25, 2016 and this is your first ever post. What kinda time warp have you been sleeping through ??????? Six years of nothing. Are you a Chicago Democrat ..... wow...............MW 
Comment by CrackpotJackpot on Nov 14, 2022 9:47pm
So you don't know if it's over?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities